Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7349)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2021 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ostios-Garcia L, Villamayor J, Garcia-Lorenzo E, Vinal D, Feliu J. Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer. World J Gastroenterol 2021; 27(40): 6775-6793 [PMID: 34790007 DOI: 10.3748/wjg.v27.i40.6775] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i40/6775.htm |
| Number | Citing Articles |
| 1 |
Dashuai Yang, Fangrui Zhao, Yang Su, Yu Zhou, Jie Shen, Kailiang Zhao, Youming Ding. Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1184708
|
| 2 |
Abdullah Khalid, Zohaa Faiz, Manav Shah, Elliot Newman, Daniel A. King, Danielle DePeralta, Sepideh Gholami, Matthew J. Weiss, Marcovalerio Melis. Factors Influencing Immunotherapy Utilization in Stage IV Pancreatic Cancer: Impact of Race and Socioeconomics in the U.S. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-024-01119-2
|
| 3 |
Donglin Jiang, Yangxue Wu, Ling Liu, Yajing Shen, Tiandong Li, Yin Lu, Peng Wang, Changqing Sun, Kaijuan Wang, Keyan Wang, Hua Ye. Burden of Gastrointestinal Tumors in Asian Countries, 1990–2021: An Analysis for the Global Burden of Disease Study 2021. Clinical Epidemiology 2024; : 587 doi: 10.2147/CLEP.S472553
|
| 4 |
Wenkai Jiang, Caifei Xiang, Yan Du, Xiao Li, Xin Li, Wence Zhou. Time trend of pancreatic cancer mortality in the Western Pacific Region: age-period-cohort analysis from 1990 to 2019 and forecasting for 2044. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11369-1
|
| 5 |
Ying Huang, Zhenhua Yang, Lei Zhang. Polyphenol Supplementation Enhances the Efficacy of PD-1/PD-L1 Inhibitors Against Cancer: A Meta-Analysis of Animal Studies. Nutrition and Cancer 2024; 76(1): 17 doi: 10.1080/01635581.2023.2277477
|
| 6 |
Melanie Herpels, Jun Ishihara, Anguraj Sadanandam. The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunities. The Journal of Pathology 2023; 260(5): 533 doi: 10.1002/path.6171
|
| 7 |
Zhichen Jiang, Xiaohao Zheng, Min Li, Mingyang Liu. Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges. Frontiers of Medicine 2023; 17(6): 1135 doi: 10.1007/s11684-023-1050-6
|
| 8 |
Haoyang Mi, Shamilene Sivagnanam, Courtney B. Betts, Shannon M. Liudahl, Elizabeth M. Jaffee, Lisa M. Coussens, Aleksander S. Popel. Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers. Cancer Research 2022; 82(23): 4359 doi: 10.1158/0008-5472.CAN-22-1190
|
| 9 |
Yuming Zhang, Helei Hou, Xuchen Zhang, Hongwei Lan, Xingfa Huo, Xueqin Duan, Yufeng Li, Xiaochun Zhang, Na Zhou. CD8 + T-Cell-Related Genes: Deciphering Their Role in the Pancreatic Adenocarcinoma TME and Their Effect on Prognosis. Digestive Diseases and Sciences 2024; doi: 10.1007/s10620-024-08715-z
|
| 10 |
Irene Pérez-Díez, Zoraida Andreu, Marta R. Hidalgo, Carla Perpiñá-Clérigues, Lucía Fantín, Antonio Fernandez-Serra, María de la Iglesia-Vaya, José A. Lopez-Guerrero, Francisco García-García. A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments. Cancers 2023; 15(11): 2887 doi: 10.3390/cancers15112887
|
| 11 |
Shuo Jian, Dehua Kong, Jieli Tian. Expression of miR-425-5p in Pancreatic Carcinoma and Its Correlation with Tumor Immune Microenvironment. Journal of Investigative Surgery 2023; 36(1) doi: 10.1080/08941939.2023.2216756
|
| 12 |
Rui Zheng, Xiaobin Liu, Yufu Zhang, Yongxian Liu, Yaping Wang, Shutong Guo, Xiaoyan Jin, Jing Zhang, Yuehong Guan, Yusi Liu. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1383978
|
| 13 |
Milan Vošmik, Stanislav John, Josef Dvořák, Beatrice Mohelníková-Duchoňová, Bohuslav Melichar, Radka Lohynská, Aleš Ryška, Aml Mustafa Banni, Johana Krempová, Igor Sirák. Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial. Oncology and Therapy 2024; 12(4): 817 doi: 10.1007/s40487-024-00309-z
|
| 14 |
Giulia Lencioni, Alessandro Gregori, Belén Toledo, Rita Rebelo, Benoît Immordino, Manoj Amrutkar, Cristina P.R. Xavier, Anja Kocijančič, Deo Prakash Pandey, Macarena Perán, Justo P. Castaño, Naomi Walsh, Elisa Giovannetti. Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems. Seminars in Cancer Biology 2024; : 217 doi: 10.1016/j.semcancer.2024.09.002
|
| 15 |
Hyun-Ah Kim, Hyunsoo Kim, Min-Kyung Nam, Jong Kook Park, Moo-Yeal Lee, Seok Chung, Kyung-Mi Lee, Hyo-Jeong Kuh. Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03064-9
|
| 16 |
Xin Xiang, Xuejie Chen, Yue He, Yiwei Wang, Weitong Xia, Shuyu Ye, Sidan Wang, Yi Xiao, Quansi Li, Xiaoyan Wang, Weiwei Luo, Jingbo Li. Pancreatic cancer challenge in 52 Asian countries: age-centric insights and the role of modifiable risk factors (1990-2019). Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1271370
|
| 17 |
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, Zong-Hao Duan, Hong-Fei Yao, Jian Yang, Yong-Wei Sun, Shu-Heng Jiang, De-Jun Liu, Yan-Miao Huo. Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment. Cellular Oncology 2023; 46(1): 17 doi: 10.1007/s13402-022-00741-1
|
| 18 |
Ana Leda F. Longhini, Inés Fernández-Maestre, Margaret C. Kennedy, Matthew G. Wereski, Shoron Mowla, Wenbin Xiao, Scott W. Lowe, Ross L. Levine, Rui Gardner. Development of a customizable mouse backbone spectral flow cytometry panel to delineate immune cell populations in normal and tumor tissues. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1374943
|